PATENT CLAIM ANALYSIS

Application Number: 16034209
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "235100"]

Abstract:
A CyaA-deficient  B. pertussis  mutant was constructed and used in a vaccine. The pertussis-specific antibody profile and Th17 response induced by vaccination with the mutant was surprisingly comparable to that induced by  B. pertussis  strains not deficient in CyaA.

Claim (Index 10):
The vaccine of  claim 1 , wherein the vaccine is provided in a single dosage form which comprises at least 1\u00d710 7  CFU of the strain.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.28125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14870487', '15477562', '12224895', '15472436', '14658817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7710384032501424
- 35 USC 102 Novelty (BERT): 0.6133372070819739
- Combined Prediction Score: 0.7552682836333255
- Mean Citation Score: 481.023476
- Max Citation Score: 586.9137
- Similarity Product: 468.599200581944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test